TABLE 2.
Means (SDs) for Y-BOCS, GAD-7, PHQ-9, DOCS-SF, OCI-R, and WSAS.
| Measure | Treatment | Pre | Post | 3-m FU | 6-m FU | Effect size (d) within group | Effect size (d) between groups post-treatment | ||||
| M (SD) | M (SD) | M (SD) | M (SD) | pre–post | pre-3-m FU | pre-6-m FU | B4DT vs. SH | B4DT vs. WL | SH vs. WL | ||
| Y-BOCS | B4DT | 26.75 (4.23) | 10.90 (4.35) | 8.56 (5.75) | 9.17 (6.89) | 3.75 | 4.30 | 4.16 | 2.57 | 3.86 | 0.51 |
| SH | 27.88 (4.22) | 24.63 (6.18) | 0.77 | ||||||||
| WL | 26.88 (3.93) | 27.32 (4.14) | –0.11 | ||||||||
| DOCS-SF | B4DT | 26.56 (3.81) | 13.44 (7.08) | 10.69 (8.18) | 12.00 (8.16) | 3.44 | 4.17 | 3.82 | 1.65 | 1.87 | 0.10 |
| SH | 28.69 (3.61) | 24.63 (6.47) | 0.57 | ||||||||
| WL | 28.56 (6.29) | 25.24 (5.43) | 0.53 | ||||||||
| OCI-R | B4DT | 22.69 (12.42) | 7.94 (5.94) | 6.13 (5.48) | 8.06 (8.16) | 1.19 | 1.33 | 1.18 | 1.38 | 1.67 | 0.24 |
| SH | 29.25 (15.29) | 22.00 (13.14) | 0.47 | ||||||||
| WL | 27.69 (14.42) | 25.19 (13.38) | 0.17 | ||||||||
| PHQ-9 | B4DT | 10.06 (4.60) | 5.81 (4.37) | 4.81 (3.97) | 5.44 (3.77) | 0.92 | 1.14 | 1.00 | 1.44 | 1.74 | 0.04 |
| SH | 16.31 (5.69) | 12.63 (5.06) | 0.65 | ||||||||
| WL | 12.50 (3.65) | 12.48 (3.21) | 0.01 | ||||||||
| GAD-7 | B4DT | 10.69 (4.21) | 6.81 (3.89) | 5.00 (3.71) | 6.68 (4.69) | 0.92 | 1.35 | 0.95 | 1.24 | 1.24 | 0.04 |
| SH | 13.81 (3.97) | 12.44 (5.10) | 0.35 | ||||||||
| WL | 13.60 (4.85) | 12.24 (4.81) | 0.28 | ||||||||
| WSAS | B4DT | 15.13 (8.31) | − | 6.19 (7.48) | 6.38 (6.04) | − | 1.08 | 1.05 | – | – | – |
| SH | 19.38 (7.20) | 18.19 (6.93) | 0.17 | ||||||||
| WL | 21.81 (7.16) | 20.27 (6.51) | 0.22 | ||||||||
Y-BOCS, Yale-Brown Obsessive Compulsive Scale; GAD-7, generalized anxiety disorder-7; PHQ-9, patient health questionnaire-9; DOCS-SF, dimensional obsessive compulsive scale – short form; OCI-R, obsessive compulsive inventory – revised; WSAS, work and social adjustment scale.